News | October 21, 2024
Senores Pharmaceuticals gets SEBI nod for IPO
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The company is one of the most profitable companies manufacturing speciality chemicals in India
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
The companies plan to use the proceeds to retire debt and expand operations
TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
Subscribe To Our Newsletter & Stay Updated
